NEWS AMC Cancer Institute Publishes Comprehensive ‘Outcomes Book’ on Cancer Treatment Performance 2024.06.21

Includes Quantitative and Qualitative Indicators such as the Number of Cancer Surgeries and Procedures, Survival Rates, and the History and Status of AMC Cancer Institute

“Providing Objective Information with as Many Indicators as Possible Related to Cancer Treatment… Committed to Being a Trusted Hospital for Patients”


▲ The medical staff from the AMC Cancer Institute are discussing cancer treatment outcomes and future operational plans.


Asan Medical Center (AMC) Cancer Institute has released a detailed report analyzing the performance of its cancer treatment services based on objective metrics.


The publication, titled ‘Outcomes Book,’ presents quantitative indicators, such as the number of cancer surgeries and procedures, as well as qualitative indicators, including five-year survival rates, providing a thorough overview of AMC Cancer Institute’s cancer treatment outcomes and history.


The ‘Outcomes Book’ is designed to offer cancer patients transparent information about the treatment performance of Asan Medical Center, thereby enhancing trust and demonstrating the commitment of Asan Medical Center to maintaining and improving a patient-centered, high-quality cancer treatment system.


The report includes treatment performance data up to 2022 for common cancers in Korea, such as liver cancer, colorectal cancer, stomach cancer, breast cancer, and lung cancer. It features quantitative indicators like the annual 6,200 multidisciplinary care and an average of 1,600 stomach cancer surgeries per year, alongside qualitative indicators such as a 92.6% five-year survival rate for rectal cancer surgery and a 93.6% rate of minimally invasive lung cancer surgeries.


In addition, the report discloses 74 indicators covering radiation and systemic chemotherapy cases, average hospitalization duration, and complication rates for the five types of cancer, demonstrating that the cancer treatment outcomes of Asan Medical Center are on par with leading global cancer institutions.


Specific detailed indicators unique to Asan Medical Center are also included, such as the proportion of ABO-incompatible liver transplantation for liver cancer, the conversion-to-surgery rate in intractable liver metastasis patients through multidisciplinary care, and the number of implant and autologous tissues in immediate reconstructions for breast cancer.


The report also delves into the history and current status of AMC Cancer Institute, highlighting initiatives like Korea’s first ‘Multidisciplinary Cancer Care Center’ established in 2006, the ‘Life Care Center for Cancer Patients’ aimed at improving the quality of life for cancer patients, and cutting-edge facilities such as the ‘Cancer Institute Data Center,’ ‘Center for Personalized Cancer Medicine,’ ‘CAR T-Cell Therapy Center,’ and ‘Theranostics Center.’


The ‘Outcomes Book’ is accessible on the AMC Cancer Institute website [Homepage Link]. Future updates will include additional statistics for other types of cancer.


President Tae Won Kim of AMC Cancer Institute (Professor of Oncology) stated “We have included as many indicators as possible in the ‘Outcomes Book’ to provide cancer patients with transparent and reliable information about the performance of AMC Cancer Institute. We will continue to strive to lead the field of cancer treatment and research globally and to be a trusted hospital for our patients.”


Notably, Asan Medical Center has been recognized as a leading hospital for surgeries, achieving significant milestones such as the world’s first 10,000 laparoscopic stomach cancer surgeries by 2018, Korea’s first 30,000 colorectal cancer surgeries by 2018, and Korea’s first 40,000 breast cancer surgeries by 2021.